1. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the Task Force of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39(33):3021-3104. doi:10.1093/eurheartj/ehy339
2. Covella M, Milan A, Totaro S, et al. Echocardiographic aortic root dilatation in hypertensive patients: a systematic review and meta-analysis. J Hypertens. 2014;32(10):1928-1935. doi:10.1097/HJH. 0000000000000286
3. DePaolo J, Levin MG, Tcheandjieu C, et al. Relationship between ascending thoracic aortic diameter and blood pressure: a Mendelian randomization study.Arterioscler Thromb Vasc Biol. 2023;43(2):359-366. doi:10.1161/ATVBAHA.122.318149
4. Mancusi C, Basile C, Fucile I, et al. Aortic remodeling in patients with arterial hypertension: pathophysiological mechanisms, therapeutic interventions and preventive strategies-a position paper from the heart and hypertension working group of the Italian society of hypertension.High Blood Press Cardiovasc Prev. 2025;32(3):255-273. doi:10.1007/s40292-025-00710-3
5. Fujikura K, Albini A, Barr RG, et al. Aortic enlargement in chronic obstructive pulmonary disease (COPD) and emphysema: the Multi-Ethnic Study of Atherosclerosis (MESA) COPD study.Int J Cardiol. 2021;331:214-220. doi:10.1016/j.ijcard.2021.02.017
6. Liang X, Chou OHI, Cheung BM. The association between systemic arterial hypertension and chronic obstructive pulmonary disease. Results from the U.S. National Health and Nutrition Examination Survey 1999-2018: a cross-sectional study.Chronic Obstr Pulm Dis. 2023;10(2):190-198. doi:10.15326/jcopdf.2022.0306
7. Ando K, Kaneko N, Doi T, Aoshima M, Takahashi K. Prevalence and risk factors of aortic aneurysm in patients with chronic obstructive pulmonary disease.J Thorac Dis. 2014;6(10):1388-1395. doi:10.3978/j.issn.2072-1439.2014.10.01
8. Piccari L, Del Pozo R, Blanco I, et al. Association between systemic and pulmonary vascular dysfunction in COPD.Int J Chron Obstruct Pulmon Dis. 2020;15:2037-2047. doi:10.2147/COPD.S257679
9. Polman R, Hurst JR, Uysal OF, Mandal S, Linz D, Simons S. Cardiovascular disease and risk in COPD: a state of the art review.Expert Rev Cardiovasc Ther. 2024;22(4-5):177-191. doi:10.1080/14779072.2024. 2333786
10. Fisk M, Cheriyan J, Mohan D, et al. Vascular inflammation and aortic stiffness: potential mechanisms of increased vascular risk in chronic obstructive pulmonary disease.Respir Res. 2018;19(1):100. doi:10.1186/s12931-018-0792-1
11. Chen T, Yang X, Fang X, et al. Potential influencing factors of aortic diameter at specific segments in population with cardiovascular risk.BMC Cardiovasc Disord. 2022;22(1):32. doi:10.1186/s12872-022-02479-y
12. Mensel B, Heßelbarth L, Wenzel M, et al. Thoracic and abdominal aortic diameters in a general population: MRI-based reference values and association with age and cardiovascular risk factors.Eur Radiol. 2016;26(4):969-978. doi:10.1007/s00330-015-3926-6
13. Guo X, Wang Y, Li H, et al. Relationship between ascending thoracic aortic diameter and blood pressure: a cross-sectional CT study. Arteriosclerosis, Thrombosis, Vasc Biol. 2022;42(7):1345-1353. doi:10. 1161/ATVBAHA.122.318149
14. Hatemi A, Yao Y, Xu M, et al. Risk factors for dilatation of ascending, arch, and descending aorta: a population-based cohort. J Am College Cardiol. 2022;78(7):678-690.
15. Xiong J, Wu Z, Chen C, Guo W. Chronic obstructive pulmonary disease effect on the prevalence and postoperative outcome of abdominal aortic aneurysms: a meta-analysis.Sci Rep. 2016;6:25003. doi:10.1038/srep 25003
16. Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter.J Thorac Imaging. 1999;14(4):270-278. doi:10.1097/00005382-199910000-00007
17. Chettrit D, Amitai OB, Tamir I, et al. PHT-bot: a deep learning system for pulmonary hypertension risk stratification in COPD. Proceedings of SPIE. 2019;10950:171-178. doi:10.1117/12.2512469
18. Mohamed Hoesein FA, Besselink T, Pompe E, et al. Accuracy of CT pulmonary artery diameter for pulmonary hypertension in end-stage COPD. Lung. 2016;194(5):813-819. doi:10.1007/s00408-016-9926-8
19. Cuttica MJ, Bhatt SP, Rosenberg SR, et al. Pulmonary artery to aorta ratio is associated with cardiac structure and functional changes in mild-to-moderate COPD.Int J Chron Obstruct Pulmon Dis. 2017;12: 1439-1446. doi:10.2147/COPD.S131413
20. Barr RG. The epidemiology of vascular dysfunction relating to chronic obstructive pulmonary disease and emphysema.Proc Am Thorac Soc. 2011;8(6):522-527. doi:10.1513/pats.201101-008MW
21. Andersen KH, Iversen M, Kjaergaard J, et al. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease.J Heart Lung Transplant. 2012;31(4): 373-380. doi:10.1016/j.healun.2011.11.020
22. Terzikhan N, Bos D, Lahousse L, et al. Pulmonary artery to aorta ratio and risk of all-cause mortality in the general population: the Rotterdam study. Eur Respir J. 2017;49(6):1602168. doi:10.1183/13993003.02168-2016
23. Janda S, Shahidi N, Gin K, Swiston J. Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysis. Heart. 2011;97(8):612-622. doi:10.1136/hrt.2010.212084
24. Labaki WW, Agusti A, Bhatt SP, et al. Using CT to detect COPD and comorbidities. Am J Respiratory Crit Care Med.2024;210(3):281-287. doi:10.1164/rccm.202402-0407PP<strong></strong>
25. Rueda-Ochoa OL, Bons LR, Zhu F, et al. Thoracic aortic diameter and cardiovascular events and mortality among women and men.Radiology. 2022;304(1):208-215. doi:10.1148/radiol.210861